Article
Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs
2019-07-11
Abstract excerpt
There is increasing momentum toward the development of gene therapy for heart failure (HF), cardiomyopathy, and other progressive cardiac diseases that correlate with impaired calcium (Ca 2+ ) transport and reduced contractility. We have used FRET between fluorescently-tagged SERCA2a (the cardiac Ca 2+ pump) and PLB (its ventricular peptide inhibitor) to test directly the effectiveness of loss-of-inhibition/gain...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 97e6030e-745e-53ff-9a27-7677c016fee7
- DOI
- 10.1101/699975
